A phase 1, open-label, multi-center, non randomised, dose escalation study to evaluate the safety, tolerability and pharmacokinetic profile of XNW7201 in subjects with advanced solid tumors [XNW7201-1-02).

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date22/07/19 → 31/12/24

Keywords

  • Medical Oncology
  • Solid Tumors
  • Clinical trial